GGrantIndex
Sort

53,477 grants matching addiction

ORWH: SCOR on Sex and Gender Factors Afecting Women's Health

$991,355
Rajita Sinha · Yale University · P50 · FY2011 · DA

Functional & Structural Connectivity of Alcohol Use Disorders

$991,300
Abdolreza Momenan · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2018 · AA

Animal MRI/MRS Methodological Development for Drug Addiction Applications

$991,173
Yihong Yang · National Institute On Drug Abuse · ZIA · FY2019 · DA

Modeling the effects of chronic marijuana use on neuroinflammation and HIV-related neuronal injury

$991,003
Christina S Meade · Duke University · R01 · FY2021 · DA

Orbitrap Fusion Lumos ETD Mass Spectrometer

$990,760
Lauren Elizabeth Ball · Medical University Of South Carolina · S10 · FY2018 · OD

Overcoming Tramadol Resistance In CYP2D6 Poor Metabolizers: A Phase 1 Trial Demonstrating Analgesic Superiority of Omnitram to Tramadol in Subjects Coadministered Paroxetine

$990,418
Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2016 · DA

FY23. TO 10 - CTN CLINICAL COORDINATING CENTER - CTN-0144. PERIOD OF PERFORMANCE: SEPTEMBER 7, 2023, TO DECEMBER 31, 2027

$990,350
Eve Jelstrom · The Emmes Company, Llc · N01 · FY2023 · DA

Attack Major Source of Abused Opioids: Molecularly Deactivate Unused Rx Opioids

$990,284
Thomas E Jenkins · Elysium Therapeutics, Inc. · R44 · FY2019 · DA

SOAR: Smartphones for Opioid Addiction Recovery

$989,878
Paul W Glimcher · New York University School Of Medicine · R01 · FY2021 · DA

Enhancing the Access and Quality of Medication-Assisted Treatment (MAT) for Individuals with Opioid Use Disorder (OUD) in Rural Pennsylvania’s Medicaid Primary Care Practices

$989,714
Ellen Didomenico · Pennsylvania Department Of Human Services · R18 · FY2017 · HS

ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT

$989,570
University Of Utah · N01 · FY2000 · DA

WormBase: a core data resource for C elegans and other nematodes

$989,492
Paul Warren Sternberg · California Institute Of Technology · P41 · FY2009 · HG

MRI: Acquisition of Thorny Flat Next Generation Cluster for High-Performance Computing in West Virginia

$989,408
Blake Mertz · West Virginia University Research Corporation · · FY2017 · CSE

Development of synthetic sphingolipids for prostate cancer therapy

$989,405
Alison Nicole McCracken · Siege Pharmaceuticals, Inc. · R44 · FY2021 · CA

IGF::OT::IGF: PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA. N01DA-17-8932.

$989,205
Patrick Beardsley · Virginia Commonwealth University · N01 · FY2019 · DA

Case Proteomics Center for HIV/AIDS and Drug Abuse

$989,108
Mark R Chance · Case Western Reserve University · P20 · FY2009 · DA

Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements

$987,966
Tuan Le Mau · Pascall Systems, Incorporated · R42 · FY2024 · DA

Clinical Trials Network: North Texas Node

$987,791
University Of Texas Sw Med Ctr/Dallas · U10 · FY2005 · DA

The Neuroproteomics and Neurometabolomics Center on Cell-Cell Signaling

$987,731
Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2014 · DA

Control Of Behavior By Drug Injections

$987,702
Steven Goldberg · National Institute On Drug Abuse · ZIA · FY2013 · DA

Attack Major Source of Abused Opioids: Molecularly Deactivate Unused Rx Opioids

$986,904
Thomas E Jenkins · Elysium Therapeutics, Inc. · R44 · FY2017 · DA

Center on Molecular and Cell Biology of Drug Abuse

$986,855
University Of Minnesota Twin Cities · P50 · FY2003 · DA

Biological And Biochemical Characterization Of Sigma Receptors

$986,688
Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2016 · DA

Epigenetic susceptibility of behavioral and addictive disorders during pre/pubescence after natural disaster exposures in-utero

$986,519
Yoko Nomura · Queens College · R01 · FY2023 · DA

Molecular profile of proviral reservoirs in HIV-infected drug users

$986,339
Xu Yu · Massachusetts General Hospital · R33 · FY2022 · DA